Mufson Howe Hunter, Investment Bankers for Growth

Life Science Tools & Services

The path by which new drugs are discovered and produced is fraught with developmental and regulatory risk.  Life Science tools  and service companies, while dependent upon the ability of the pharmaceutical and biotech industries to finance research and development, minimize the ambiguities of the drug discovery process and the vagaries of the business cycle.  Furthermore, tools and service companies benefit from the growing trend to outsource services as biotech and pharmaceutical companies focus on their core competencies and seek to shed costs better borne by those with expertise and the ability to leverage costs across many industry participants. Mufson Howe Hunter maintains important relationships with both institutional investors and strategic buyers in this indusrty vertical.